DUBLIN, September 15, 2017 /PRNewswire/ --
The "Global Microwave Ablation Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to Research and Markets' offering.
The Global Microwave Ablation Devices Market is estimated to witness a CAGR of 14.8% during the forecast period 2017-2023. The market is analyzed based on three segments, namely product type, end-users, and regions.
The market is dominated by Medtronic, AngioDynamics, NeuWave Medical (now Johnson & Johnson), MedWaves, and Perseon which has more than 75% market share in the Global Microwave Ablation Devices market. Factors, such as the increased prevalence of chronic disorders, growing popularity about minimally invasive surgeries, focus on early prevention, and the increase in disposable income, are driving the market growth.
The rise in awareness about minimally invasive surgeries or procedures has created a high adoption as it is less painful, performed as an outpatient procedure, and unlike traditional open surgeries they are less expensive. Minimally invasive surgeries are emerging as potential replacements for conventional therapeutic cancer surgeries for the treatment of various tumors of the prostate gland, lungs, and liver.
Further, robotic navigation technologies that perform microwave ablation procedures more accurately are being incorporated to increase the popularity of these surgeries. The cost of microwave tissue ablation treatment is directly proportional to the size of the tissue/tumor and the number of probes required for the surgery.
The major products in the market include:
- Acculis MTA System
- NEUWAVE Microwave Ablation System
- Evident MW Ablation System
- AveCure Microwave System
- MicroThermX Devices
Key Topics Covered:
1 Industry Outlook
2 Report Outline
3 Market Snapshot
4 Market Outlook
5 Product Type: Market Size and Analysis
8 Regions: Market Size and Analysis
9 Competitive Landscape
10 Vendor Profiles
11 Companies to Watch For
- AngioDynamics, Inc.
- Emblation Microwave.
- Johnson & Johnson (NeuWave Medical)
- Medtronic PLC
- MedWaves, Inc
- Miramar Labs.
- Symple Surgical
- Urologix, LLC
For more information about this report visit https://www.researchandmarkets.com/research/m5tvbq/global_microwave
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets